Kemal Malik

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew Bartholomae, Attorney-in-fact for Kemal Malik
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kemal Malik:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Director Common Stock 11,133 $94,073 $8.45 02 Jan 2026 Direct
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 7,800 $6,162 $0.7900 02 Jan 2026 Direct
ACCELERON PHARMA INC Director Common Stock 0 $29.37 19 Nov 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 19 Nov 2021 Direct

Insider Reports Filed by Kemal Malik

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 16:19
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 16:19
RNAC Cartesian Therapeutics, Inc. 01 Jul 2024 2 $0 4 Director 03 Jul 2024, 16:10
RNAC Cartesian Therapeutics, Inc. 01 Jul 2024 0 $0 3 Director 03 Jul 2024, 16:07
XLRN ACCELERON PHARMA INC 19 Nov 2021 3 $0 4 Director 22 Nov 2021, 08:11